APUS
+$0
250,000 sh
APUS
Apimeds Pharmaceuticals US, Inc.
SEC CIK 1894525
$0.8580
−92.5% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
9
Most recent
Net income (FY2025)
−$6M
Reported
Total assets
$164.18M
Balance sheet
Source
SEC XBRL
From 10-K/10-Q
Advertisement
At a glance
Insiders at APUS have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.
Largest recent trade: Inscobee Inc., APUS's 10% owner, spent $2M of their own money on 500,000 shares at $4, growing their stake 34%.
Most active filer: Inscobee Inc., with 4 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for APUS, newest firstAPUS
+$0
750,000 sh
APUS
Kim Christopher, APUS's Chair, spent $14.4K of their own money on 7,730 shares at $2, growing their stake 39%.
+$14.4K
7,730 sh @ $2
APUS
Kim Christopher, APUS's Chair, spent $36K of their own money on 19,770 shares at $2, opening a brand-new position.
+$36K
19,770 sh @ $2
APUS
Koo Jakap, APUS's Director, spent $56.7K of their own money on 28,500 shares at $2, growing their stake 5%.
+$56.7K
28,500 sh @ $2
Advertisement
APUS
Inscobee Inc., APUS's 10% owner, spent $2M of their own money on 500,000 shares at $4, growing their stake 34%.
+$2M
500,000 sh @ $4
APUS
+$473.2K
182,002 sh @ $3
APUS
+$184.8K
71,090 sh @ $3
APUS
+$114.5K
44,041 sh @ $3
Advertisement
About APUS insider activity
This page tracks every recent Form 4 filed for Apimeds Pharmaceuticals US, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is APUS insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for Apimeds Pharmaceuticals US, Inc. usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.